Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane
NCT ID: NCT01199471
Last Updated: 2012-01-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4000 participants
OBSERVATIONAL
2010-09-30
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Practice of Inhalation Anesthesia With Sevoflurane in China
NCT01715857
Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia
NCT01191476
The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics
NCT03588429
Effect of Fentanyl on Coughing and Recovery After Anesthesia With an LMA Laryngeal Mask Airway)for Airway Management
NCT01368809
The Effect of Sevoflurane on Airway Hyperreactivity During the Perioperative Period.
NCT06694675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chinese Patients Requiring Surgery with Anesthesia
Chinese patients 18 to 70 years of age, meeting the American Society of Anesthesiologists (ASA) Physical Status Class 1 (normal healthy), Class 2 (mild systemic disease), or Class 3 (severe systemic disease), who underwent surgery requiring general anesthesia (sevoflurane) administered per local Prescribing Information and endotracheal intubation or laryngeal mask airway (LMA).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age from 18 to 70 years
3. Surgery requiring general anesthesia with endotracheal intubation or laryngeal mask airway.
Exclusion Criteria
2. Hypersensitivity or unusual response to any halogenated anesthetics.
3. Personal or familial history of malignant hyperthermia.
4. Female patients either pregnant or breast feeding.
5. General anesthesia is administered with total intravenous anesthesia (TIVA) of propofol.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rundo-Cronova International Pharmaceuticals Research & Development Co., Ltd.
UNKNOWN
Abbott
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yue Kang, MD
Role: STUDY_DIRECTOR
Abbott
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site Reference ID/Investigator# 43073
Guangzhou, Guangdong, China
Site Reference ID/Investigator# 43072
Guangzhou, Guangdong, China
Site Reference ID/Investigator# 46407
Guangzhou, Guangdong, China
Site Reference ID/Investigator# 43076
Guangzhou, Guangdong, China
Site Reference ID/Investigator# 43077
Guangzhou, Guangdong, China
Site Reference ID/Investigator# 43066
Harbin, Heilongjiang, China
Site Reference ID/Investigator# 43068
Harbin, Heilongjiang, China
Site Reference ID/Investigator# 43071
Wuhan, Hubei, China
Site Reference ID/Investigator# 43070
Wuhan, Hubei, China
Site Reference ID/Investigator# 43065
Chengdu, Sichuan, China
Site Reference ID/Investigator# 43064
Chengdu, Sichuan, China
Site Reference ID/Investigator# 43056
Beijing, , China
Site Reference ID/Investigator# 43060
Beijing, , China
Site Reference ID/Investigator# 46406
Beijing, , China
Site Reference ID/Investigator# 43058
Beijing, , China
Site Reference ID/Investigator# 44382
Beijing, , China
Site Reference ID/Investigator# 43059
Beijing, , China
Site Reference ID/Investigator# 43062
Beijing, , China
Site Reference ID/Investigator# 43063
Beijing, , China
Site Reference ID/Investigator# 43061
Beijing, , China
Site Reference ID/Investigator# 43057
Beining, , China
Site Reference ID/Investigator# 44384
Daqing, , China
Site Reference ID/Investigator# 44383
Guangzhou, , China
Site Reference ID/Investigator# 43074
Guangzhou, , China
Site Reference ID/Investigator# 43067
Harbin, , China
Site Reference ID/Investigator# 43051
Jiangsu, , China
Site Reference ID/Investigator# 43015
Shanghai, , China
Site Reference ID/Investigator# 43017
Shanghai, , China
Site Reference ID/Investigator# 41554
Shanghai, , China
Site Reference ID/Investigator# 46405
Shanghai, , China
Site Reference ID/Investigator# 43012
Shanghai, , China
Site Reference ID/Investigator# 43014
Shanghai, , China
Site Reference ID/Investigator# 43011
Shanghai, , China
Site Reference ID/Investigator# 43018
Shanghai, , China
Site Reference ID/Investigator# 46404
Shanghai, , China
Site Reference ID/Investigator# 43069
Wuhan, Hubei, , China
Site Reference ID/Investigator# 43052
Zhejiang, , China
Site Reference ID/Investigator# 43053
Zhejiang, , China
Site Reference ID/Investigator# 43054
Zhejiang, , China
Site Reference ID/Investigator# 43055
Zhejiang, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P12-563
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.